Special report: cardiovascular pharmacogenomics

Technol Eval Cent Assess Program Exec Summ. 2007 Nov;22(7):1-4.
No abstract available

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology*
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / genetics*
  • Cardiovascular System / drug effects
  • Diuretics / pharmacology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Pharmacogenetics* / methods

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Diuretics
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors